BCRX Operating Cash Flow (Statement)
Biocryst Pharmaceuticals Inc · Operating Cash Flow (Statement)
BCRX Operating Cash Flow (Statement)
Latest reported$359.87Mperiod ending
BCRX Cash from Operations (-$6.50M → $359.87M)
Annual operating cash flow (statement)
High-resolution chart · PNG
BCRX operating cash flow (statement) history
Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Operating Cash Flow (Statement) (USD) |
|---|---|
| 329,880,000 | |
| -52,020,000 | |
| -95,141,000 | |
| -161,850,000 | |
| -142,157,000 | |
| -137,216,000 | |
| -89,584,000 | |
| -92,565,000 | |
| -41,143,000 | |
| -53,438,000 | |
| -13,116,000 | |
| -38,551,000 | |
| -26,530,000 | |
| -37,397,000 | |
| -32,251,000 | |
| -28,554,221 | |
| -16,218,470 | |
| -20,873,820 | |
| -24,997,799 | |
| -15,211,315 | |
| -23,346,157 | |
| -18,151,335 | |
| -11,196,000 | |
| -16,364,055 | |
| -10,158,486 | |
| -3,177,640 | |
| -4,900,000 | |
| -4,200,000 | |
| -10,300,000 | |
| -6,800,000 | |
| -7,700,000 | |
| -6,500,000 |